Vimachem - IIoT Pharma 4.0 AI Platform ads

𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝘁𝗵𝗲 𝗻𝗲𝘄 𝗩𝗶𝗺𝗮𝗰𝗵𝗲𝗺 Our new brand identity reflects who we are today and the future we’re building: helping pharmaceutical manufacturers make high-quality medicines more safely, efficiently and reliably. At its heart is the V rooted in our name. Its flexible form reflects a platform that adapts to the way manufacturers work, with 𝗼𝗳𝗳-𝘁𝗵𝗲-𝘀𝗵𝗲𝗹𝗳, 𝗿𝗲𝗮𝗱𝘆-𝘁𝗼-𝗱𝗲𝗽𝗹𝗼𝘆 applications that connect and grow as their needs evolve. Together with a more distinctive color palette, it gives the precision, energy and ambition behind our work a clearer visual expression. That identity also reflects the way we work: combining strong engineering, deep pharma expertise and close collaboration with the people putting our technology into practice. Our AI-powered Pharma MES brings that ambition to the shop floor: purpose-built for pharma, off-the-shelf and ready-to-deploy. It helps manufacturing teams turn digital transformation into measurable progress. To our customers, partners and team: thank you for helping shape Vimachem and being part of what comes next. Discover our new look in the video below and read more about the thinking behind our rebrand via the link in the comments. Transforming pharma manufacturing, one batch at a time. #Vimachem #PharmaManufacturing #MES #Pharma40

𝗙𝗿𝗼𝗺 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗳𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝗚𝗠𝗣 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀. That was the central theme of the 𝗩𝗶𝗺𝗮𝗰𝗵𝗲𝗺 𝗣𝗵𝗮𝗿𝗺𝗮 𝗗𝗶𝗴𝗶𝘁𝗶𝘇𝗮𝘁𝗶𝗼𝗻 & 𝗔𝗜 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲, bringing together pharmaceutical manufacturers, industry partners, and leading experts in AI and GMP. The sessions explored that journey, starting with the foundations manufacturers need to put in place: 𝗧𝗵𝗲𝗿𝗲 𝗶𝘀 𝗻𝗼 𝘀𝗵𝗼𝗿𝘁𝗰𝘂𝘁 𝗳𝗿𝗼𝗺 𝗽𝗮𝗽𝗲𝗿 𝘁𝗼 𝗔𝗜. Before AI can deliver meaningful value in pharmaceutical manufacturing, companies need the right foundations: digital execution, connected systems, controlled workflows, and reliable, contextualized manufacturing data. But technology is only half the equation. 𝗔𝗜 𝗶𝗻 𝗚𝗠𝗣 𝗮𝗹𝘀𝗼 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗮 𝗱𝗲𝗲𝗽 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗼𝗳 𝘁𝗵𝗲 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸. Sessions with Brandi Stockton and Frank Henrichmann explored the ISPE GAMP Guide: Artificial Intelligence, draft EU GMP Annex 22, and validation of AI-enabled systems. NNIT addressed building a roadmap from digitalization to AI delivery, while Accenture examined deterministic workflows versus agents on the shop floor. We also heard directly from pharmaceutical manufacturers, including IBERFAR, Indústria Farmacêutica S.A. and PharmaPath, about the practical challenges of moving from digitization toward AI, alongside panel discussions that brought pharmaceutical leaders together to share their experiences and explore what it takes to prepare GMP operations for AI. 𝗙𝗿𝗼𝗺 𝘁𝗵𝗲𝗼𝗿𝘆 𝘁𝗼 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲. The Vimachem product team demonstrated AI agents for batch record and logbook digitization, as well as Batch Review, showing how AI capabilities can be integrated into Pharma MES workflows. These capabilities are being developed with the emerging Annex 22 requirements in mind, while we continue exploring the potential of dynamic, adaptive, and probabilistic AI models as the regulatory framework evolves. 𝗧𝗵𝗲 𝗴𝗼𝗮𝗹 𝗶𝘀 𝗻𝗼𝘁 𝗺𝗼𝗿𝗲 𝗶𝘀𝗼𝗹𝗮𝘁𝗲𝗱 𝗔𝗜 𝗽𝗶𝗹𝗼𝘁𝘀. 𝗜𝘁 𝗶𝘀 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝗚𝗠𝗣 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀. A big thank you to our speakers, customers, industry partners, and ISPE for contributing to such valuable discussions and helping advance the responsible adoption of AI in pharmaceutical manufacturing. 🎥 Watch the conference highlights below and 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝘁𝗼 𝗿𝗲𝗰𝗲𝗶𝘃𝗲 𝘁𝗵𝗲 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗿𝗲𝘀𝗼𝘂𝗿𝗰𝗲𝘀 through the link in the comments. #AIinPharma #PharmaManufacturing #PharmaMES #GMP #ISPE #DigitalManufacturing #VimachemConference

𝗠𝗲𝗲𝘁 𝗩𝗶𝗺𝗮𝗰𝗵𝗲𝗺 𝗮𝘁 𝗣𝗵𝗮𝗿𝗺𝗮 𝗠𝗘𝗦 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟲 We’re heading to Berlin on October 1–2 to discuss the next steps in pharma manufacturing digitalization, from connected operations and better use of production data to practical AI applications in GMP environments. Our Co-Founder and CEO, Alex Vidras, will present: 𝗕𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗲 𝗔𝗜 𝗣𝗶𝗹𝗼𝘁: 𝗙𝗿𝗼𝗺 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁 𝗔𝗜 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 He’ll explore a practical roadmap from paper processes and fragmented data to AI-enabled GMP operations, and what manufacturers need to put in place to move beyond isolated pilots. 𝗔𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗣𝗵𝗮𝗿𝗺𝗮 𝗠𝗘𝗦 𝗘𝘂𝗿𝗼𝗽𝗲? Come and meet the Vimachem team at 𝗕𝗼𝗼𝘁𝗵 𝟳 to see the Vimachem Pharma MES Platform and discuss your manufacturing priorities. #PharmaMES #PharmaManufacturing #MES #DigitalManufacturing #GMP

𝗟𝗶𝘃𝗲 𝗳𝗿𝗼𝗺 𝗔𝘁𝗵𝗲𝗻𝘀: 𝗚𝗿𝗲𝗲𝗰𝗲 𝗮𝘁 𝘁𝗵𝗲 𝗙𝗼𝗿𝗲𝗳𝗿𝗼𝗻𝘁 𝗼𝗳 𝗔𝗜 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 We are honored to welcome the Minister of Health, Adonis Georgiadis to the Vimachem Pharma Digitization & AI Conference. Addressing an audience of senior leaders from across pharmaceutical manufacturing, the Minister highlighted how Greece is positioning itself at the forefront of AI in pharma, and how the Greek Government is actively supporting the digital transformation of the sector. For an industry where more than half of organizations are still largely paper-based, as this morning's live poll showed, public support for digitization is a critical enabler. Moving from paper to connected systems, and from connected systems to AI, takes investment, skills and the right policy environment. More highlights coming up throughout the day. #VimachemConference #PharmaManufacturing #AIinPharma #DigitalTransformation #Greece #ISPE #GMP #DigitalManufacturing #Innovation

𝗠𝗲𝗲𝘁 𝗼𝘂𝗿 𝘀𝗽𝗲𝗮𝗸𝗲𝗿: 𝗙𝗿𝗮𝗻𝗸 𝗛𝗲𝗻𝗿𝗶𝗰𝗵𝗺𝗮𝗻𝗻 We are delighted to welcome Frank Henrichmann, Senior Executive Consultant at QFINITY Quality Management and Chair of the ISPE GAMP® Global Steering Committee, to the Vimachem Pharma Digitization & AI Conference. Frank will present “From Guide to Practice: Validating AI-Supported Systems in GMP.” His session will examine what effective human oversight really means when AI is used in a GxP environment. A qualified person signing off an AI-generated output is not enough. The review process must be designed so that errors can genuinely be detected, escalated and addressed. Frank will explore: · How established GAMP 5 principles apply to AI-supported systems. · What pharma manufacturers should consider when assessing and qualifying AI technology vendors. · Why human-in-the-loop oversight can fail in practice. · How to match controls to certainty, criticality and risk. · How monitoring, change governance and periodic re-verification help maintain the validated state after go-live. Learn more about a day bringing pharma experts and leaders together for strategic discussions, practical takeaways and valuable networking focused on the future of AI in pharmaceutical manufacturing at the link below. #PharmaAI #GAMP5 #GxP #AIValidation #PharmaceuticalManufacturing #DigitalTransformation #Vimachem

𝗠𝗲𝗲𝘁 𝗩𝗶𝗺𝗮𝗰𝗵𝗲𝗺 𝗮𝘁 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟲 This October, we’re bringing pharma-focused digital manufacturing and practical AI to Milan 2026. Visit us at 𝗕𝗼𝗼𝘁𝗵 𝟴𝗝𝟰𝟰 to discover how the Vimachem Pharma MES Platform helps pharmaceutical and biopharmaceutical manufacturers: • Digitize execution with Electronic Batch Records and eLogbooks. • Turn manufacturing data into actionable insights with AI. • Improve OEE and reduce downtime. • Strengthen compliance and data integrity. • Scale digital transformation across lines and sites. If you’re exploring MES solutions, practical AI applications in manufacturing, or a more flexible way to digitize your facility, come and speak with our team. 📍 CPHI, Milan 📅 6–8 October 2026 📌 Booth 8J44 Book a meeting with us from the link in the comments below. #CPHI #CPHIMilan #PharmaManufacturing #MES #ArtificialIntelligence #DigitalTransformation #Pharma40 #Biopharma